{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:43:43Z","timestamp":1790649823774,"version":"4.1.0"},"reference-count":50,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100021078","name":"Norwegian Institute of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021078","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>The World Health Organisation aims to eliminate hepatitis C virus (HCV) infection as a public health threat by 2030. We assessed progress towards HCV elimination in Norway until the end of 2024. We used linked national registry data to describe diagnosed cases of HCV infection by treatment uptake and case characteristics, and the incidence of HCV\u2010related death. We updated a stochastic compartmental model to estimate HCV incidence and prevalence among people who inject drugs and migrants. We summarised all available data to assess progress towards HCV elimination targets. Among 12,620 HCV RNA\u2010positive cases still living in Norway in 2024, 10,824 (86%) had been treated. Among people who inject drugs the estimated incidence was 20 (95% credible interval (CrI): 8\u201339) new infections, or 0.3 per 100 (95% CrI: 0.1\u20130.5), and the estimated prevalence was 1498 (95% Crl, 549\u20133631) chronic infections in 2024. Among migrants, prevalence increased from 598 (95% CrI: 179\u20131156) in 2021 to 2228 (95% CrI: 1394\u20133071) in 2024. HCV\u2010related deaths plateaued at 0.6\u20130.8 per 100,000 from 2017\u20132024. Norway achieved global targets for HCV incidence, mortality, treatment uptake, harm reduction and (likely) blood safety. There is a lack of data on the target for diagnostic coverage. We conclude that Norway has entered a new phase of the HCV epidemic, with low incidence of new infections, low mortality, and with prevalence becoming more influenced by patterns of migration. Further decentralisation and integration of testing and treatment are necessary to reach new national goals.<\/jats:p>","DOI":"10.1111\/jvh.70202","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:00:46Z","timestamp":1789372846000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Progress Towards Eliminating Hepatitis C as a Public Health Threat in Norway"],"prefix":"10.1111","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2810-7734","authenticated-orcid":false,"given":"Robert","family":"Whittaker","sequence":"first","affiliation":[{"name":"Department of Infection Control and Vaccines Norwegian Institute of Public Health  Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda Cou\u00ebssurel","family":"W\u00fcsthoff","sequence":"additional","affiliation":[{"name":"Unit for Clinical Research on Addictions Oslo University Hospital  Oslo Norway"},{"name":"Norwegian Centre for Addiction Research University of Oslo  Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen Eriksson","family":"Midtb\u00f8","sequence":"additional","affiliation":[{"name":"Department of Method Development and Analytics Norwegian Institute of Public Health  Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5vard","family":"Midgard","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Oslo University Hospital  Oslo Norway"},{"name":"Institute of Clinical Medicine University of Oslo  Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Dalgard","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine University of Oslo  Oslo Norway"},{"name":"Department of Infectious Diseases Akershus University Hospital  L\u00f8renskog Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"e_1_2_13_2_1","volume-title":"Global Hepatitis Report 2026","author":"World Health Organization (WHO)","year":"2026"},{"key":"e_1_2_13_3_1","volume-title":"Global Health Sector Strategies on, Respectively, HIV, Viral Hepatitis and Sexually Transmitted Infections for the Period 2022\u20132030","author":"WHO","year":"2022"},{"key":"e_1_2_13_4_1","volume-title":"Guidance for Country Validation of Viral Hepatitis Elimination and Path to Elimination","author":"WHO","year":"2023"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.01.013"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.028"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2022.5699"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00364-3"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00137-0"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(25)00068-8"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7330a1"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2025.2569504"},{"key":"e_1_2_13_13_1","unstructured":"Polaris Observatory Countries\/Territories\u2014Maps 2026 https:\/\/cdafound.org\/polaris\u2010countries\u2010maps\/."},{"key":"e_1_2_13_14_1","volume-title":"Statusrapport om Eliminasjon av Hepatitt B og C som Folkehelseproblem i Norge: Oppf\u00f8lging av den Nasjonale Strategien mot Virale Hepatitter [In Norwegian]","author":"The Norwegian Institute of Public Health","year":"2023"},{"key":"e_1_2_13_15_1","volume-title":"Nasjonal Strategi for Arbeidet mot Virale Leverbetennelser (Hepatitter) [In Norwegian]","author":"Ministry of Health and Care Services","year":"2016"},{"key":"e_1_2_13_16_1","volume-title":"Nasjonal Strategi mot Hepatitter [In Norwegian]","author":"Ministry of Health and Care Services","year":"2018"},{"key":"e_1_2_13_17_1","volume-title":"Nasjonal Strategi for F\u00f8rebygging og Kontroll av Hepatitt B og C [In Norwegian]","author":"Ministry of Health and Care Services","year":"2026"},{"key":"e_1_2_13_18_1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction Viral Hepatitis Elimination Barometer Among People Who Inject Drugs in Europe 2023 https:\/\/www.emcdda.europa.eu\/publications\/data\u2010factsheet\/viral\u2010hepatitis\u2010elimination\u2010barometer\u2010among\u2010people\u2010who\u2010inject\u2010drugs\u2010in\u2010europe_en."},{"key":"e_1_2_13_19_1","unstructured":"The Norwegian Directorate of Health Hepatitt C: Nasjonale Faglige R\u00e5d [In Norwegian] 2026 https:\/\/www.helsedirektoratet.no\/faglige\u2010rad\/hepatitt\u2010c."},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103165"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104044"},{"key":"e_1_2_13_22_1","volume-title":"Conference of the International Network on Health and Hepatitis in Substance Users","author":"Thingnes G.","year":"2021"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15266"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003653"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad711"},{"key":"e_1_2_13_26_1","unstructured":"Helsedata Data Sources 2026 https:\/\/helsedata.no\/en\/data\u2010sources\/?page=1&sort=0."},{"key":"e_1_2_13_27_1","unstructured":"The Norwegian Tax Administration National Population Register 2026 https:\/\/www.skatteetaten.no\/en\/person\/national\u2010registry\/."},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae147"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2025.2530203"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560\u20107917.ES.2024.29.46.2400180"},{"key":"e_1_2_13_31_1","volume-title":"Prevention and Control of Infectious Diseases Among People Who Inject Drugs: 2023 Update","author":"European Centre for Disease Prevention and Control (ECDC) and European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)","year":"2023"},{"key":"e_1_2_13_32_1","unstructured":"Norwegian Directorate of Health Helsetjenestetilbudet Til Asyls\u00f8kere Flyktninger og Familiegjenforente [In Norwegian] 2026 https:\/\/www.helsedirektoratet.no\/veiledere\/helsetjenester\u2010til\u2010asylsokere\u2010flyktninger\u2010og\u2010familiegjenforente."},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30366-6"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/v16060858"},{"key":"e_1_2_13_35_1","unstructured":"Swedish Association of Local Authorities and Regions Nationell Elimineringsplan: Plan f\u00f6r Eliminering av Hepatit C [In Swedish] 2022 https:\/\/kunskapsstyrningvard.se\/download\/18.5b09432e198bb8aaa3a5cf01\/1756129546167\/Hepatit\u2010C\u2010elimineringsplan\u2010220915.pdf."},{"key":"e_1_2_13_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00346-6"},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104279"},{"key":"e_1_2_13_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101145"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2025.101482"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13197"},{"key":"e_1_2_13_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30505-2"},{"key":"e_1_2_13_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00471-4"},{"key":"e_1_2_13_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00335-7"},{"key":"e_1_2_13_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-025-01245-5"},{"key":"e_1_2_13_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae107"},{"key":"e_1_2_13_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13626"},{"key":"e_1_2_13_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-16017-8"},{"key":"e_1_2_13_48_1","unstructured":"Norwegian Directorate of Immigration Har Ankommet 92 000 Ukrainere [In Norwegian] 2026 https:\/\/www.udi.no\/aktuelt\/har\u2010ankommet\u201092\u2010000\u2010ukrainere\/."},{"key":"e_1_2_13_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00472-6"},{"key":"e_1_2_13_50_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560\u20107917.ES.2025.30.29.2500015"},{"key":"e_1_2_13_51_1","unstructured":"UK Health Security Agency Hepatitis C in England 2024 2026 https:\/\/www.gov.uk\/government\/publications\/hepatitis\u2010c\u2010in\u2010the\u2010uk\/hepatitis\u2010c\u2010in\u2010england\u20102024."}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.70202","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvh.70202","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.70202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:42:27Z","timestamp":1790581347000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.70202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1111\/jvh.70202"],"URL":"https:\/\/doi.org\/10.1111\/jvh.70202","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"2026-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70202"}}